Bellen Chemistry Co., Ltd. is a leading chemistry service provider in the biotechnology and pharmaceutical industries, founded in 2007 in China. The company's slogan "Strive to be your first choice of a chemistry service provider based on specialized and innovative solutions" encapsulates its commitment to excellence. Bellen Chemistry offers comprehensive chemistry solutions through its Contract Chemistry Service Organization (CCSO), catering to the needs of big pharmas, biotech innovators, and new drug development institutions. With nearly 1,000 employees globally, of which the technical team accounts for around 50%, Bellen Chemistry has established itself as a key player in the industry. The company's recent Series C investment of $30.00M in September 27, 2018, led by Qianhai Fund of Funds, Apricot Capital, CMB International Capital Corporation, Zhongjin Qichen, Junlian Yikang, and QianHai Equity Investment, reflects investor confidence in its vision and capabilities. Bellen Chemistry is dedicated to fostering innovation, talent acquisition, and expanding its capability and capacity to offer an integrated one-stop-shop chemistry service platform. This commitment positions the company to provide its global partners with open, complete, reliable, and efficient research and manufacturing solutions.
No recent news or press coverage available for Bellen Chemistry Co., Ltd..